Terns Pharmaceuticals, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€92.46K - Gross profit
-€92.46K - SG&A expenses
€28.55M - R&D expenses
€61.85M - EBITDA
-€87.16M - D&A
€452.02K - EBIT
-€90.49M - Interest expenses
€0.00 - EBT
-€78.32M - Tax expenses
€66.78K - Net income
-€78.54M
Cash flow statement
- Net deferred tax
-€125.85K - Non-cash items
€149.82K - Changes in working capital
€6.13M - Operating cash flow
-€63.66M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
-€30.08M - Total cash dividends paid
€0.00 - Issuance of common stock
€138.95M - Debt repayment
€0.00 - Other financing cash flow
€1.22M - Net financing cash flow
€140.39M - Foreign exchange effects
-€17.12K - Net change in cash
€46.63M - Cash at end of period
€124.96M - Free cash flow
-€63.66M
Balance sheet
- Cash and cash equivalents
€124.96M - Cash and short-term investments
€270.05M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€3.00M - Total current assets
€273.05M - Property, plant & equipment
€947.69K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€304.77K - Total non-current assets
€1.25M - Total assets
€274.30M - Accounts payable
€2.44M - Short-term debt
€380.10K - Other current liabilities
€6.88M - Total current liabilities
€11.06M - Long-term debt
€1.18M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€1.36M - Total non-current liabilities
€1.95M - Total liabilities
€13.00M - Common stock
€7.70K - Retained earnings
-€401.92M - Other equity
-€18.83K - Total equity
€261.30M - Total liabilities and shareholders' equity
€274.30M
Company information
- Market capitalization
€285.32M - Employees
59 - Enterprise Value
€220.30M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-30.1% Much better than peer group: -54.5% - ROA
-
-28.6% Much better than peer group: -50.7% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-22.3% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.33M